)
Visual
test
Imeik Technology Development Co
Imeik Technology Development Co (300896) investor relations material
Imeik Technology Development Co Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary20 Mar, 2026
Executive summary
Revenue for 2025 was ¥2.45 billion, down 18.94% year-over-year; net profit attributable to shareholders was ¥1.29 billion, down 34.05% year-over-year.
Gross margin declined from 94.64% to 92.70%, reflecting increased competition and market pressure.
The company completed the acquisition of REGEN (Korea), adding global products AestheFill and PowerFill to its portfolio.
R&D investment reached ¥359.7 million, 14.67% of revenue, with 61 new patent applications and 22 SCI articles published.
New products, including Minoxidil topical solution and botulinum toxin, received regulatory approval and will expand the product matrix.
Financial highlights
Operating income: ¥2.45 billion, down 18.94% year-over-year.
Net profit attributable to shareholders: ¥1.29 billion, down 34.05% year-over-year.
Operating cash flow: ¥1.32 billion, down 31.29% year-over-year.
Basic and diluted EPS: ¥4.28, down 34.15% year-over-year.
Total assets: ¥8.91 billion, up 6.80% from prior year-end.
Net assets attributable to shareholders: ¥7.58 billion, down 2.73% from prior year-end.
Quarterly revenue and profit declined sequentially throughout the year.
Outlook and guidance
The company expects the medical aesthetics industry to maintain a 10% CAGR through 2028, despite a shift from rapid expansion to high-quality growth.
Strategic focus will be on R&D innovation, international expansion, and full-category product ecosystem development.
2026 plans include further global integration, new product launches, and digital transformation of marketing and service platforms.
Explain the ~27% solution and gel revenue decline
AestheFill distribution arbitration status
Injectable Botulinum Toxin Type A launch strategy
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Imeik Technology Development Co
- Revenue and net profit rose over 5% year-over-year, with high margins and strong R&D investment.300896
Q4 202422 Dec 2025 - Revenue and profit declined significantly, impacted by costs and acquisition-related changes.300896Q3 202522 Dec 2025
- Revenue and profit fell, but global expansion and high margins support long-term growth.300896Q2 202519 Aug 2025
- Revenue and net profit rose year-over-year, while EPS declined due to share capital expansion.300896Q3 202413 Jun 2025
- Revenue and net profit grew over 13% and 16% year-over-year, driven by strong core product sales.300896Q2 202413 Jun 2025
- Q1 2025 saw double-digit declines in revenue and profit amid a tough market environment.300896Q1 20256 Jun 2025
Imeik Technology Development Co
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage